Cargando…
Dihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin
Adriamycin, a widely used anthracycline antibiotic in multiple chemotherapy regimens, has been challenged by the cardiotoxicity leading to fatal congestive heart failure in the worst condition. The present study demonstrated that Dihydromyricetin, a natural product extracted from ampelopsis grossede...
Autores principales: | Zhu, Hong, Luo, Peihua, Fu, Yingying, Wang, Jincheng, Dai, Jiabin, Shao, Jinjin, Yang, Xiaochun, Chang, Linlin, Weng, Qinjie, Yang, Bo, He, Qiaojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413651/ https://www.ncbi.nlm.nih.gov/pubmed/25226612 |
Ejemplares similares
-
Autophagy protects against dasatinib-induced hepatotoxicity via p38 signaling
por: Yang, Xiaochun, et al.
Publicado: (2015) -
Digoxin Enhances the Anticancer Effect on Non-Small Cell Lung Cancer While Reducing the Cardiotoxicity of Adriamycin
por: Wang, Yingying, et al.
Publicado: (2020) -
Diosmetin protects against retinal injury via reduction of DNA damage and oxidative stress
por: Shen, Zeren, et al.
Publicado: (2015) -
Adriamycin cardiotoxicity monitoring by radionuclide scan.
por: Robinson, B. A., et al.
Publicado: (1983) -
A Comprehensive Review of Clinical Cardiotoxicity Incidence of FDA-Approved Small-Molecule Kinase Inhibitors
por: Jin, Ying, et al.
Publicado: (2020)